These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 5243952

  • 1. Treatment of 100 cases of chronic myeloid leukemia with Myleran.
    Pawelski S, Topolska P, Rechowicz K, Krzyzanowska-Wozniakowska.
    Pol Med Sci Hist Bull; 1968 Jul; 11(3):101-4. PubMed ID: 5243952
    [No Abstract] [Full Text] [Related]

  • 2. [Survival of 29 cases of chronic myeloid leukemia treated by myleran].
    Petitclerc C, Barry A.
    Union Med Can; 1976 Feb; 105(2):210-6. PubMed ID: 1069396
    [No Abstract] [Full Text] [Related]

  • 3. [Course and prognosis of chronic myeloid leukemia treated with busulfan. Study of 300 cases].
    Ionescu V.
    Dtsch Med Wochenschr; 1971 May 14; 96(20):867-70. PubMed ID: 5280862
    [No Abstract] [Full Text] [Related]

  • 4. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
    Larrain C, Cruz A, Codoceo V.
    Rev Med Chil; 1984 Sep 14; 112(9):898-911. PubMed ID: 6598227
    [No Abstract] [Full Text] [Related]

  • 5. Prolonged remission in chronic myeloid leukemia after a single course of myleran.
    Djaldetti M, Pinkhas J, Padeh B, De Vries A.
    Isr J Med Sci; 1965 Jul 14; 1(4):827-8. PubMed ID: 5216389
    [No Abstract] [Full Text] [Related]

  • 6. [Serious hematological accidents due to Myleran in the treatment of chronic myeloid leukemia].
    Olmer J, Muratore R, Gabriel B, Canu AM.
    Mars Med; 1968 Jul 14; 105(4):330-8. PubMed ID: 5245481
    [No Abstract] [Full Text] [Related]

  • 7. [Toxic effects of busulfan (myleran) in the treatment of chronic myeolid leukemia].
    Japp H.
    Schweiz Med Wochenschr; 1974 Aug 10; 104(32):1115-9. PubMed ID: 4548568
    [No Abstract] [Full Text] [Related]

  • 8. [Observations on the terminal course of chronic myeloid leukemia treated by alkylating agents (busulfan)].
    Giovanelli E.
    Minerva Med; 1970 May 19; 61(37):2038-41. PubMed ID: 4097050
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of chronic myeloid leukemia with repeated single doses of busulfan.
    Sullivan JR, Hurley TH, Bolton JH.
    Cancer Treat Rep; 1977 May 19; 61(1):43-5. PubMed ID: 266418
    [Abstract] [Full Text] [Related]

  • 10. [Analysis of results of treatment with myleran in 100 cases of chronic myelogenous leukemia].
    Pawelski S, Topolska P, Rechowicz K, Krzyzanowska-Woźniakows.
    Pol Arch Med Wewn; 1968 May 19; 41(2):249-57. PubMed ID: 5248892
    [No Abstract] [Full Text] [Related]

  • 11. [Pulmonary fibrosis after busulfan therapy].
    Jandl H, Franke A, Albrecht G.
    Z Gesamte Inn Med; 1975 Dec 15; 30(24):799-801. PubMed ID: 1062873
    [Abstract] [Full Text] [Related]

  • 12. [Chronic granulocytic leukaemia (CGL): results of continuous busulphan mono-chemotherapy in 160 cases (1960-1980) (author's transl)].
    Sánchez Fayos J, Outeiriño J, de Villalobos E, Valera M, Alonso M, Calabuig MT, Paniagua G.
    Sangre (Barc); 1981 Dec 15; 26(1):65-71. PubMed ID: 6942520
    [No Abstract] [Full Text] [Related]

  • 13. [Indirubin in the treatment of chronic myelocytic leukemia (CML)--estimation of labelling index of bone marrow cells by 3H-TdR].
    You YC, Mi JX, Wan JH, Yang TY, Wang ZC, Qian LS.
    Zhonghua Zhong Liu Za Zhi; 1987 Nov 15; 9(6):418-20. PubMed ID: 3482992
    [Abstract] [Full Text] [Related]

  • 14. [Clinical heterogeneity of Myleran-induced pneumopathy. Apropos of 2 further cases and review of the literature].
    Gyger M, LeGresley LP, Boulianne P, Lacombe M, Lavallée R, Bonny Y, Boileau J, D'Angelo G.
    Union Med Can; 1977 Nov 15; 106(11):1522-8. PubMed ID: 270864
    [No Abstract] [Full Text] [Related]

  • 15. Results in the treatment of chronic myeloid leukaemia.
    Nasr AL, Aboul-Enein M, Tawfik HN.
    Haematologica; 1972 Apr 15; 57(11):794-802. PubMed ID: 4200314
    [No Abstract] [Full Text] [Related]

  • 16. Preliminary observation of good response to Busulfan (myleran) in an advanced case of extensive psoriasis.
    Ray RN, Bhattacharyya K, Ray R.
    Indian J Dermatol; 1983 Jan 15; 28(1):37-9. PubMed ID: 6574105
    [No Abstract] [Full Text] [Related]

  • 17. [Modification of the prognosis of chronic myeloid leukemia through current treatment].
    Donner L, Klener P, Roth Z.
    Vnitr Lek; 1976 Feb 15; 22(2):114-9. PubMed ID: 1062868
    [No Abstract] [Full Text] [Related]

  • 18. [Terminal phase of chronic granulocytic leukemia].
    Pawlowski J.
    Pol Tyg Lek; 1969 Jan 06; 24(1):14-7. PubMed ID: 5255159
    [No Abstract] [Full Text] [Related]

  • 19. [Long-term treatment of chronic myeloid leukemia by Chinese medicines alternating cyclically with myleran].
    Zhang ZN.
    Zhong Xi Yi Jie He Za Zhi; 1985 Feb 06; 5(2):80-2, 66. PubMed ID: 3157487
    [No Abstract] [Full Text] [Related]

  • 20. The long-term results and survival in the treatment of chronic granulocytic leukaemia with Myleran.
    Chrobák L, Radochová D, Chrobáková H.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1969 Feb 06; 12(5):565-70. PubMed ID: 5267593
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.